The Effect of Intraurethral Lidocaine Gel on Pain Perception During Flexible Cystoscopy
NCT ID: NCT03874364
Last Updated: 2019-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
280 participants
INTERVENTIONAL
2019-02-01
2021-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study the impact of lidocaine gel, patient counseling and monitoring regarding pain perception during flexible cystoscopy are investigated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Lidocaine Gel in Reducing Foley Catheter Discomfort in Surgical Patients
NCT02709304
Effect of Urethral Analgesia on Voiding
NCT02823431
Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy
NCT03382743
Lidocaine for Pain After Urodynamic Testing
NCT03390790
Lidocaine Spray Use on Patients Comfort in Undergoing Bladder Catheterization
NCT06585748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lidocaine gel, counselling, monitor
Lidocaine gel
10 ml 2% lidocaine gel is instilled with a syringe through the length of the urethra and kept in site at least 5 minutes prior the introduction of the cystoscope.
Counselling
Patients receive a brochure in the waiting room explaining the procedure in details.
Monitor
Patients are allowed to view and follow the procedure on a monitor connected to the cystoscope's camera.
Lidocaine gel, counselling, no monitor
Lidocaine gel
10 ml 2% lidocaine gel is instilled with a syringe through the length of the urethra and kept in site at least 5 minutes prior the introduction of the cystoscope.
Counselling
Patients receive a brochure in the waiting room explaining the procedure in details.
No monitor
Patients are not allowed to view and follow the procedure on a monitor connected to the cystoscope's camera.
Lidocaine gel, no counselling, monitor
Lidocaine gel
10 ml 2% lidocaine gel is instilled with a syringe through the length of the urethra and kept in site at least 5 minutes prior the introduction of the cystoscope.
Monitor
Patients are allowed to view and follow the procedure on a monitor connected to the cystoscope's camera.
No counselling
Patients won't receive a brochure in the waiting room explaining the procedure in details.
Lidocaine gel, no counselling, no monitor
Lidocaine gel
10 ml 2% lidocaine gel is instilled with a syringe through the length of the urethra and kept in site at least 5 minutes prior the introduction of the cystoscope.
No counselling
Patients won't receive a brochure in the waiting room explaining the procedure in details.
No monitor
Patients are not allowed to view and follow the procedure on a monitor connected to the cystoscope's camera.
Lubricating gel, counselling, monitor
Counselling
Patients receive a brochure in the waiting room explaining the procedure in details.
Monitor
Patients are allowed to view and follow the procedure on a monitor connected to the cystoscope's camera.
Lubricating gel
10 ml plain lubrificant gel is instilled with a syringe through the length of the urethra and kept in site at least 5 minutes prior the introduction of the cystoscope.
Lubricating gel, counselling, no monitor
Counselling
Patients receive a brochure in the waiting room explaining the procedure in details.
Lubricating gel
10 ml plain lubrificant gel is instilled with a syringe through the length of the urethra and kept in site at least 5 minutes prior the introduction of the cystoscope.
No monitor
Patients are not allowed to view and follow the procedure on a monitor connected to the cystoscope's camera.
Lubricating gel, no counselling, monitor
Monitor
Patients are allowed to view and follow the procedure on a monitor connected to the cystoscope's camera.
Lubricating gel
10 ml plain lubrificant gel is instilled with a syringe through the length of the urethra and kept in site at least 5 minutes prior the introduction of the cystoscope.
No counselling
Patients won't receive a brochure in the waiting room explaining the procedure in details.
Lubricating gel, no counselling, no monitor
Lubricating gel
10 ml plain lubrificant gel is instilled with a syringe through the length of the urethra and kept in site at least 5 minutes prior the introduction of the cystoscope.
No counselling
Patients won't receive a brochure in the waiting room explaining the procedure in details.
No monitor
Patients are not allowed to view and follow the procedure on a monitor connected to the cystoscope's camera.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lidocaine gel
10 ml 2% lidocaine gel is instilled with a syringe through the length of the urethra and kept in site at least 5 minutes prior the introduction of the cystoscope.
Counselling
Patients receive a brochure in the waiting room explaining the procedure in details.
Monitor
Patients are allowed to view and follow the procedure on a monitor connected to the cystoscope's camera.
Lubricating gel
10 ml plain lubrificant gel is instilled with a syringe through the length of the urethra and kept in site at least 5 minutes prior the introduction of the cystoscope.
No counselling
Patients won't receive a brochure in the waiting room explaining the procedure in details.
No monitor
Patients are not allowed to view and follow the procedure on a monitor connected to the cystoscope's camera.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Given indication for flexible cystoscopy
* Written informed consent
Exclusion Criteria
* Urinary tract infection
* Use of analgesics in the previous 24 hours and chronic intake of analgesics
* Dementia
* Presence of a sensory disorder such as or spinal cord injury
* Indwelling catheter carrier
18 Years
80 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ajet Hyseni
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ajet Hyseni
Dr.med.univ.RKS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik für Urologie, Kantonsspital Luzern
Lucerne, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Lidocaine-study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.